This study was designed to investigate which cellular, transcriptional and signaling programs are associated with the development of colitis in cancer patients being treated with immune checkpoint inhibitors (ICIs).
The U.S. Preventive Services Task Force now recommends women start getting mammograms at age 40, as breast cancer rates are increasing in younger women.
PBS series NOVA talks with Mass General Brigham oncologists and radiologists about new tools that use artificial intelligence (AI) tools to predict cancer.
Researchers from the Krantz Center for Cancer Research wanted to see if they could increase the number of new cancer drivers that could be targeted by uncovering what proteins were druggable across cancer.
Leaders from the Mass General Cancer Center will present research discoveries and outcomes from clinical trials in cancer at the 2024 American Association for Cancer Research (AACR) Annual Meeting, held April 5-10, in San Diego.
The MGH LVC, the hospital’s volunteer-led auxiliary group, is dedicated to helping patients who have lost their hair due to cancer or other medical treatments through its Images Oncology Boutique, a shop specializing in prosthetics and wigs.
It’s fitting that the investigators who developed a new CAR T-based treatment for glioblastoma called their treatment platform “CAR-TEAM” cells, as it took a true team effort to bring their concept from the lab to the clinic.
Learn more about the findings and importance of a study led by a research and clinical team from the Mass General Cancer Center who is developing new cell therapy for patients with recurrent glioblastoma.
Targeted therapy and world-class care at Mass General Cancer Center has given Ann Malik a new lease on life and a passion for inspiring others. Read her story.
A collaborative project by Mass General Cancer Center researchers to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.
An integral part of one of the world’s most distinguished academic medical centers, Mass General Cancer Center is among the leading cancer care providers in the United States.
